Aptus Capital Advisors, LLC Abbott Laboratories Transaction History

Aptus Capital Advisors, LLC

  • $4.95 Billion
  • Q1 2024

A detailed history of Aptus Capital Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 83,168 shares of ABT stock, worth $8.65 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
83,168
Previous 76,382 8.88%
Holding current value
$8.65 Million
Previous $8.41 Million 12.43%
% of portfolio
0.19%
Previous 0.24%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$109.52 - $120.96 $743,202 - $820,834
6,786 Added 8.88%
83,168 $9.45 Million
Q4 2023

Feb 13, 2024
SELL
$90.19 - $110.4 $68,995 - $84,456
-765 Reduced 0.99%
76,382 $8.41 Million
Q3 2023

Nov 08, 2023
BUY
$95.53 - $114.62 $1.45 Million - $1.74 Million
15,184 Added 24.5%
77,147 $7.47 Million
Q2 2023

Aug 11, 2023
SELL
$100.78 - $112.29 $375,103 - $417,943
-3,722 Reduced 5.67%
61,963 $6.76 Million
Q1 2023

May 09, 2023
SELL
$96.86 - $114.01 $490,692 - $577,574
-5,066 Reduced 7.16%
65,685 $6.65 Million
Q4 2022

Feb 13, 2023
SELL
$95.06 - $111.52 $42,967 - $50,407
-452 Reduced 0.63%
70,751 $7.77 Million
Q3 2022

Nov 02, 2022
BUY
$96.76 - $112.03 $73,827 - $85,478
763 Added 1.08%
71,203 $6.89 Million
Q2 2022

Jul 29, 2022
SELL
$102.07 - $123.37 $1.21 Million - $1.46 Million
-11,826 Reduced 14.38%
70,440 $7.65 Million
Q1 2022

May 04, 2022
BUY
$114.02 - $139.04 $1.62 Million - $1.97 Million
14,187 Added 20.84%
82,266 $9.74 Million
Q4 2021

Feb 02, 2022
BUY
$115.53 - $141.46 $829,389 - $1.02 Million
7,179 Added 11.79%
68,079 $9.58 Million
Q3 2021

Oct 27, 2021
BUY
$116.66 - $129.06 $902,365 - $998,279
7,735 Added 14.55%
60,900 $7.19 Million
Q2 2021

Jul 27, 2021
BUY
$105.79 - $124.53 $552,541 - $650,420
5,223 Added 10.89%
53,165 $6.16 Million
Q1 2021

May 06, 2021
BUY
$108.84 - $128.23 $207,013 - $243,893
1,902 Added 4.13%
47,942 $5.75 Million
Q4 2020

Feb 10, 2021
BUY
$105.0 - $114.42 $787,080 - $857,692
7,496 Added 19.45%
46,040 $5.04 Million
Q3 2020

Oct 19, 2020
SELL
$91.64 - $111.29 $694,173 - $843,021
-7,575 Reduced 16.42%
38,544 $4.19 Million
Q2 2020

Jul 22, 2020
BUY
$76.57 - $98.0 $1.02 Million - $1.31 Million
13,339 Added 40.69%
46,119 $4.22 Million
Q1 2020

May 07, 2020
BUY
$62.82 - $91.86 $2.06 Million - $3.01 Million
32,780 New
32,780 $2.59 Million
Q4 2019

Feb 10, 2020
SELL
$78.51 - $87.4 $2.45 Million - $2.73 Million
-31,179 Closed
0 $0
Q3 2019

Nov 12, 2019
SELL
$81.84 - $88.74 $242,737 - $263,202
-2,966 Reduced 8.69%
31,179 $2.61 Million
Q2 2019

Aug 13, 2019
SELL
$72.88 - $85.0 $183,584 - $214,115
-2,519 Reduced 6.87%
34,145 $2.87 Million
Q1 2019

May 15, 2019
BUY
$66.22 - $80.06 $2.43 Million - $2.94 Million
36,664 New
36,664 $2.93 Million

Others Institutions Holding ABT

# of Institutions
3,130
Shares Held
1.29B
Call Options Held
8.43M
Put Options Held
8.71M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Aptus Capital Advisors, LLC Portfolio

Follow Aptus Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aptus Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email